Surface Oncology, Inc. SURF
1.07 +1.07
Day range unavailable
52-week range unavailable
News
seekingalpha.com Tyra Biosciences: 'Hold' IR-NMIBC Data September 9th 2026, With Caution Ahead For 2027 Readouts Tyra Biosciences is downgraded to "Hold" ahead of key phase 2 SURF302 data for dabogratinib in FGFR3-altered IR-NMIBC patients. Multiple phase 2 readouts, including SURF302, SURF303, and BEACH301,…
prnewswire.com Tyra Biosciences to Host Conference Call on Initial Results of Oral Dabogratinib from the SURF302 Phase 2 Study for IR NMIBC on September 9, 2026 CARLSBAD, Calif., Sept. 4, 2026 /PRNewswire/ -- Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that target…
seekingalpha.com Tyra Biosciences: SURF302 Is A Worthwhile Binary Bet TYRA's dabogratinib has an upcoming readout in September 2026 that I think could validate its FGFR3 profile. However, if they succeed with that trial, I believe it would also help TYRA's broader SNAP…
prnewswire.com Honeywell Aerospace runway safety technology selected by Aeromexico for intended deployment on more than 100 aircraft SURF-A provides pilots with direct aural and visual alerts to avoid runway collisions FARNBOROUGH, United Kingdom, July 20, 2026 /PRNewswire/ -- Honeywell Aerospace (Nasdaq: HONA) today announced…
globenewswire.com Surface Oncology Announces ISS and Glass Lewis Both Recommend Stockholders Vote “FOR” the Proposed Merger with Coherus BioSciences Urges Stockholders to Vote Promptly to Ensure Their Shares are Represented at the September 7th Special Meeting Urges Stockholders to Vote Promptly to Ensure Their Shares are Represented at the…
businesswire.com SURFACE ONCOLOGY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Surface Oncology, Inc. - SURF NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Surface…
globenewswire.com Surface Oncology Reports Financial Results and Corporate Highlights for Second Quarter 2023 CAMBRIDGE, Mass., Aug. 02, 2023 (GLOBE NEWSWIRE) -- Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor…
businesswire.com SURFACE ONCOLOGY INVESTOR ALERT By the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Surface Oncology, Inc. - SURF NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Surface…
proactiveinvestors.com Surface Oncology stock flies on $65M stock-for-stock acquisition by Coherus BioSciences Surface Oncology shares jumped by more than 16% on Friday morning after it was revealed the clinical-stage immuno-oncology (I-O) company is being acquired by Coherus BioSciences (NASDAQ:CHRS). The…
benzinga.com US Stocks Mixed; Dow Gains 50 Points U.S. stocks traded mixed this morning, with Dow Jones gaining around 50 points on Friday. Following the market opening Friday, the Dow traded up 0.16% to 34,464.01 while the NASDAQ fell 0.14% to…
marketwatch.com Surface Oncology stock rallies on all-stock acquisition by Coherus Surface Oncology Inc. SURF, +1.37% stock is up 49% in premarket trades on Friday after the cancer drug company agreed to be acquired by Coherus BioSciences Inc. CHRS, +0.56% in a stock-for-stock deal…
headlinesoftoday.com Subsea Umbilicals, Risers, And Flow Lines (SURF) Market size to grow by USD 5.2 billion from 2022 to 2027, The surge in energy demand to drive the market growth – Technavio NEW YORK, May 11, 2023 The subsea umbilicals, risers, and flow lines (SURF) market size is estimated to increase by USD 5.2 billion from 2022 to 2027. The market is expected to grow at a CAGR of…
benzinga.com Stocks That Hit 52-Week Lows On Friday Friday's session saw 104 companies set new 52-week lows.
benzinga.com Stocks That Hit 52-Week Lows On Wednesday On Wednesday, 345 companies set new 52-week lows.
globenewswire.com Surface Oncology to Present Non-clinical Data for SRF388 and SRF114 at the Society for Immunotherapy of Cancer 2022 Annual Meeting Data further support SRF388 and SRF114 clinical development programs Data further support SRF388 and SRF114 clinical development programs
benzinga.com Stocks That Hit 52-Week Lows On Tuesday On Tuesday, 120 companies set new 52-week lows.- benzinga.com Stocks That Hit 52-Week Lows On Thursday On Thursday, 1076 companies hit new 52-week lows.
benzinga.com Stocks That Hit 52-Week Lows On Monday On Monday, 429 stocks made new 52-week lows.
globenewswire.com Surface Oncology to Present Preclinical Data Highlighting the IL-27 Gene Expression Signature in Treatment-Resistant Cancers at the 10th Annual International Cytokine and Interferon Society Meeting - New preclinical data indicate IL-27 induces a gene expression signature that has been associated with resistance to chemotherapy, radiotherapy, and checkpoint inhibition -
globenewswire.com Surface Oncology to Participate in the Baird 2022 Global Healthcare Conference CAMBRIDGE, Mass., Sept. 07, 2022 (GLOBE NEWSWIRE) -- Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor…
benzinga.com Stocks That Hit 52-Week Lows On Thursday On Thursday, 529 companies set new 52-week lows.
benzinga.com Stocks That Hit 52-Week Lows On Tuesday On Tuesday, 951 companies hit new 52-week lows.
benzinga.com Stocks That Hit 52-Week Lows On Monday During Monday's trading, 1214 companies set new 52-week lows.
globenewswire.com Surface Oncology to Present New SRF388 Clinical Data at 2022 American Society of Clinical Oncology (ASCO) Annual Meeting – SRF388 demonstrated clinical activity in multiple solid tumor types with three confirmed partial responses across NSCLC, RCC and HCC –
seekingalpha.com Surface Oncology: Neither Novartis, Nor GSK Or ARKG Is Able To Stop The Decline Surface Oncology has been a major drag for investors. There's no bad news, but there's no good news either.- benzinga.com Stocks That Hit 52-Week Lows On Tuesday On Tuesday, 540 companies set new 52-week lows.
globenewswire.com Surface Oncology to Participate in Upcoming Investor Conferences CAMBRIDGE, Mass., May 17, 2022 (GLOBE NEWSWIRE) -- Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor…
globenewswire.com Surface Oncology to Present Clinical Update on SRF388 at American Society of Clinical Oncology Annual Meeting CAMBRIDGE, Mass., April 27, 2022 (GLOBE NEWSWIRE) -- Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor…- benzinga.com Stocks That Hit 52-Week Lows On Monday On Monday, 721 companies achieved new lows for the year.
benzinga.com Stocks That Hit 52-Week Lows On Friday On Friday, 431 companies hit new 52-week lows.
benzinga.com Stocks That Hit 52-Week Lows On Thursday On Thursday, 236 companies hit new 52-week lows.- benzinga.com Stocks That Hit 52-Week Lows On Wednesday On Wednesday, 160 companies hit new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Monday On Monday, 466 companies hit new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Monday On Monday, 671 companies achieved new lows for the year.
pennystocks.com Trading Penny Stocks? Top Stock Market News for March 11th, 2022 What you need to know about trading penny stocks on March 11th The post Trading Penny Stocks? Top Stock Market News for March 11th, 2022 appeared first on Penny Stocks to Buy, Picks, News and…- benzinga.com Stocks That Hit 52-Week Lows On Tuesday Tuesday's session saw 729 companies set new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Monday On Monday, 524 stocks hit new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Friday On Friday, 368 stocks hit new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Tuesday During Tuesday's trading, 505 companies set new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Tuesday Tuesday morning saw 454 companies set new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Friday During Friday's session, 445 companies made new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Thursday On Thursday, 615 stocks hit new 52-week lows.
- benzinga.com 35 Stocks Moving In Monday's Mid-Day Session Gainers ZIVO Bioscience, Inc. (NASDAQ: ZIVO) jumped 145% to $6.86 after declining around 17% on Friday.
- benzinga.com Cathie Wood Slashes Apple Stake To Half — Also Trims Google, Fastly: What You Need To Know Cathie Wood-led Ark Investment Management nearly halved the Apple Inc (NASDAQ: AAPL) stake in the ARK Fintech Innovation ETF (NYSE: ARKF) on Thursday.
- benzinga.com 48 Stocks Moving in Tuesday's Pre-Market Session Gainers
- benzinga.com Stocks That Hit 52-Week Highs On Thursday During Thursday's morning trading, 190 companies set new 52-week highs.
- benzinga.com Stocks That Hit 52-Week Highs On Wednesday Before 10 a.m. ET on Wednesday, 375 companies hit new 52-week highs.
- benzinga.com Stocks That Hit 52-Week Highs On Friday This morning 150 companies reached new 52-week highs.
- benzinga.com Stocks That Hit 52-Week Highs On Thursday Before 10 a.m. ET Thursday, 503 stocks hit new 52-week highs.
- benzinga.com Stocks That Hit 52-Week Highs On Friday This morning 167 companies reached new 52-week highs.